Sangros Drugchem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 29 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda
- Net Worth -17.89%
- Total Assets %
About Sangros Drugchem
Sangros Drugchem Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 1996 and has a history of 29 years. Its registered office is in Alapuzha, Kerala.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Alexander Kunjummen and Thomas Alexander serve as directors at the Company.
Company Details
- LocationAlapuzha, Kerala
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231KL1996PTC009906
- Company No.
009906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Sangros Drugchem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alexander Kunjummen  | Managing Director | 04-Mar-1996 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomas Alexander | Director | 17-Jan-2015 | Current |
Financial Performance of Sangros Drugchem.
Sangros Drugchem Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sangros Drugchem?
In 2017, Sangros Drugchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sangrose Laboratories Private LimitedAlexander Kunjummen and Thomas Alexander are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sangros Drugchem?
Unlock and access historical data on people associated with Sangros Drugchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sangros Drugchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangros Drugchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
